Trastuzumab Deruxtecan

Fact of Medicine
Brand Name: Enhertu
Innovator Brand Name: Enhertu
API: Trastuzumab Deruxtecan
Packaging: 1 Vial (Per Box)
Strength: 100mg
Manufacturer Name: Daiichi Sankyo Company, Limited.


Enhertu Medication

Enhertu (trastuzumab deruxtecan) is a monoclonal antibody used to treat adult patients with unresectable or metastatic HER2+Ve breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting, and adult patients with locally advanced or metastatic HER2+Ve gastric or gastroesophageal junction adenocarcinoma who have received a prior trastuzumab-based regimen.

Dosage: The recommended enhertu dosage for breast cancer is 5.4 mg/kg and for gastric cancer is 6.4 mg/kg administered into the vein through an intravenous (IV) line. Enhertu is administered 1 time every 3 weeks (21-day treatment cycle). A doctor will determine how many treatments you need. Your healthcare provider may slow down or temporarily stop the enhertu infusion if you experience an infusion-related reaction, or permanently stop this medication if you have severe infusion reactions. In case of missed a planned enhertu dose, call your healthcare provider promptly to schedule an appointment. It is not advised to wait until the upcoming planned treatment cycle.

Side Effects: The most commonly reported enhertu side effects include:

  • Nausea
  •  Fatigue
  • Vomiting
  • Alopecia
  • Constipation
  • Decreased appetite
  • Anemia
  • Neutropenia
  •  Diarrhea
  •  Leukopenia
  • Cough
  • Thrombocytopenia

Warnings and Precautions:

  • Do not administer enhertu 100 mg injection as an intravenous push or bolus. Use of Sodium Chloride Injection must be avoided.
  • It is not recommended to substitute enhertu injection for or with trastuzumab or ado-trastuzumab emtansine.
  • Monitor patients for complete blood counts prior to starting enhertu 100 mg therapy and prior to each enhertu dose.
  •  Assess patients for LVEF before starting trastuzumab deruxtecan 100 mg and at regular intervals while on treatment.
  • Use of enhertu can be responsible for causing fetal harm when administered to a pregnant woman.

More info

Storage: Vials of (Enhertu) fam-trastuzumab deruxtecan-nxki should be stored in a refrigerator at 2°C-8°C (36°F-46°F) in the original carton in order to protect from light until the time of reconstitution. Neither freeze nor shake the reconstituted/diluted solution. Availability in India: The Indian Pharma helps connect buyers with suppliers who can ship the ENHERTU at the global level as per the needs of buyer’s. The Indian Pharma provides guarantee of quality as well as delivery for the ENHERTU Injection. Buying Procedure: In order to buy ENHERTU, you can contact us at our Toll-free number 1800 889 1064 or on WhatsApp number +919310090915 or an Email to us at: along with the genuine Identity Proof, standard Prescription letter and Medical Reports. Conclusion: Enhertu (fam-trastuzumab deruxtecan-nxki) therapy demonstrated significant enhancements in response as well as survival in comparison to the standard therapies, among recipients with HER2+Ve metastatic breast cancer and HER2+Ve gastric cancer.


What is Enhertu? Enhertu is a prescription medication approved for the treatment of breast cancer or for the treatment of gastric or gastroesophageal adenocarcinoma. What does Enhertu contain as an active substance? The medication Enhertu specifically contains the active substance Fam-Trastuzumab Deruxtecan-nxki. Is Trastuzumab Deruxtecan an FDA approved drug? Yes, Trastuzumab Deruxtecan is an FDA approved drug. How much does enhertu cost? The enhertu price in India usually may vary depending on the wholesaler/pharmacy you visit and of course the brand you choose. What is the best price for Trastuzumab Deruxtecan? Please contact Toll-free: +91 1800 889 1064|+919310090915 for trastuzumab deruxtecan price in India. We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements. Can I get Enhertu (Trastuzumab Deruxtecan) even if I am not based in India? The Indian Pharma helps patients in accessing or importing Enhertu (Trastuzumab Deruxtecan), not approved in their home country against the legitimate prescription and in conformity with the all local laws and regulations of their home country.